๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis

โœ Scribed by Michel, G; Boulad, F; Small, T N; Black, P; Heller, G; Castro-Malaspina, H; Childs, B H; Gillio, A P; Papadopoulos, E B; Young, J W


Book ID
110010187
Publisher
Nature Publishing Group
Year
1997
Tongue
English
Weight
146 KB
Volume
20
Category
Article
ISSN
0007-1188

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Extra-medullary relapse of leukemia foll
โœ W. Y. Au; Y. L. Kwong; A. K. W. Lie; S. K. Ma; R. Liang ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 208 KB ๐Ÿ‘ 2 views

The curative effect of allogeneic bone marrow transplantation (BMT) for acute and chronic leukemia is attributed to the intensive conditioning chemotherapy with or without radiotherapy, as well as an immune-mediated graft versus leukemia (GVL) effect. A different pattern of relapse has been observed

Very late relapse of chronic myelogenous
โœ Arunabh Sekhri; Delong Liu; Muhammad Rasul; Nasir Ahmed; Tauseef Ahmed; Karen Se ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 99 KB

Allogeneic stem cell transplantation is considered to be a curative treatment modality in patients with chronic myelogenous leukemia. However patients are at risk for relapse years after transplantation. Currently we present two patients who relapsed 16 and 24 years after allogeneic bone marrow tran